
Oral PCSK9 Inhibitor, Role of Neurology Department Chairs, Anti-IgLON5 Disease
17/09/2026
0:00
5:02
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the first oral PCSK9 inhibitor, the transforming role of the neurology department chair, and anti-IgLON5 disease.
D'autres épisodes de "Neurology Today in 5"



Ne ratez aucun épisode de “Neurology Today in 5” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.








